Biora Therapeutics, Inc. (BIORQ) Financials

BIORQ Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2024 14.5 million 121.1 million
June 30, 2024 18.3 million 107.6 million
March 31, 2024 23.0 million 123.2 million
Dec. 31, 2023 31.2 million 132.6 million

BIORQ Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2024 32.0 million -62000
June 30, 2024 -11.1 million 1.6 million
March 31, 2024 -12.5 million 1.5 million
Dec. 31, 2023 -13.8 million 1.5 million

BIORQ Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
Sept. 30, 2024 90.6 million
June 30, 2024 6.5 million
March 31, 2024 -4.2 million
Dec. 31, 2023 -15.6 million

BIORQ Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2024 3.2 million 14.3 million 1.1 million
June 30, 2024 5.3 million 43.8 million 1.3 million
March 31, 2024 10.8 million 43.3 million 1.5 million
Dec. 31, 2023 15.2 million 43.7 million 1.7 million

BIORQ Shares Outstanding

No data available :(

BIORQ Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2024 19000 5.6 million 10.6 million -
June 30, 2024 180000 7.7 million 8.4 million -
March 31, 2024 15000 7.0 million 9.1 million -
Dec. 31, 2023 66000 6.1 million 7.1 million -1.2 million

BIORQ Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2024 32000 -
June 30, 2024 318000 110000
March 31, 2024 542000 -
Dec. 31, 2023 872000 117000

BIORQ

Price: $0

52 week price:
0.00
0.01

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 452

Links: